Vanda Pharmaceuticals Inc (VNDA) — Cash Flow-to-Debt Ratio
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow-to-Debt Ratio of -0.18x as of December 2025, meaning its operating cash flow of $-29.42 Million could theoretically repay 0% of its total liabilities ($161.76 Million) in one year. See free cash flow generation of Vanda Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vanda Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Vanda Pharmaceuticals Inc across 22 annual periods. Also explore Vanda Pharmaceuticals Inc (VNDA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Vanda Pharmaceuticals Inc (2004–2025)
Year-by-year debt coverage analysis for Vanda Pharmaceuticals Inc. For market capitalisation and broader financial context, see Vanda Pharmaceuticals Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | $-109.44 Million | $161.76 Million | ▼ -405.2% |
| 2024 | -0.13x | $-15.76 Million | $117.66 Million | ▼ -208.3% |
| 2023 | 0.12x | $12.80 Million | $103.53 Million | ▼ -58.6% |
| 2022 | 0.30x | $31.98 Million | $107.05 Million | ▼ -58.7% |
| 2021 | 0.72x | $64.21 Million | $88.86 Million | ▲ +11.9% |
| 2020 | 0.65x | $51.77 Million | $80.19 Million | ▲ +2.3% |
| 2019 | 0.63x | $45.95 Million | $72.80 Million | ▲ +19.4% |
| 2018 | 0.53x | $29.99 Million | $56.71 Million | ▲ +2074.3% |
| 2017 | -0.03x | $-1.98 Million | $74.04 Million | ▲ +73.9% |
| 2016 | -0.10x | $-8.10 Million | $79.04 Million | ▼ -165.9% |
| 2015 | 0.16x | $12.45 Million | $80.02 Million | ▲ +102.1% |
| 2014 | -7.49x | $-81.55 Million | $10.89 Million | ▼ -1777.4% |
| 2013 | -0.40x | $-39.59 Million | $99.22 Million | ▼ -11.5% |
| 2012 | -0.36x | $-44.92 Million | $125.54 Million | ▼ -87.8% |
| 2011 | -0.19x | $-28.41 Million | $149.14 Million | ▼ -206.5% |
| 2010 | -0.06x | $-10.90 Million | $175.37 Million | ▼ -107.4% |
| 2009 | 0.84x | $169.34 Million | $202.68 Million | ▲ +107.1% |
| 2008 | -11.74x | $-45.96 Million | $3.91 Million | ▼ -198.6% |
| 2007 | -3.93x | $-51.64 Million | $13.13 Million | ▲ +27.6% |
| 2006 | -5.43x | $-51.62 Million | $9.50 Million | ▼ -56.0% |
| 2005 | -3.48x | $-17.71 Million | $5.09 Million | ▲ +26.9% |
| 2004 | -4.76x | $-8.61 Million | $1.81 Million | — |